Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001628280-19-008046
Filing Date
2019-06-17
Accepted
2019-06-17 17:14:27
Documents
10
Effectiveness Date
2019-06-17

Document Format Files

Seq Description Document Type Size
1 S-3ASR a2019junebhvns-3asr.htm S-3ASR 403084
2 exhibit43-2019junebhvnsx3a.htm EX-4.3 413330
3 EXHIBIT 5.1 exhibit51-2019junebhvnsx3a.htm EX-5.1 73888
4 EXHIBIT 5.2 exhibit52-2019junebhvnsx3a.htm EX-5.2 27511
5 EXHIBIT 10.4 exhibit104-2019junebhvnsx3.htm EX-10.4 17939
6 EXHIBIT 10.7 exhibit107-2019junebhvnsx3.htm EX-10.7 251562
7 EXHIBIT 23.1 exhibit231-2019junebhvnsx3.htm EX-23.1 2306
8 maplesgrouplogo.jpg GRAPHIC 64057
9 mapplesandcalderlogo.jpg GRAPHIC 64825
10 prospectuscover1a.jpg GRAPHIC 30721
  Complete submission text file 0001628280-19-008046.txt   1410011
Mailing Address 215 CHURCH STREET NEW HAVEN CT 06510
Business Address 215 CHURCH STREET NEW HAVEN CT 06510 203-404-0410
Biohaven Pharmaceutical Holding Co Ltd. (Filer) CIK: 0001689813 (see all company filings)

EIN.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-232167 | Film No.: 19902088
SIC: 2834 Pharmaceutical Preparations